Could a bronchial wash detect lung cancer mutations faster?

NCT ID NCT06228508

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study investigates whether a liquid biopsy taken from the airways during a bronchoscopy can help diagnose lung cancer and identify genetic mutations. The approach aims to be less invasive and faster than traditional tissue biopsies. Researchers will compare the accuracy of this bronchial fluid test against standard methods in adults undergoing bronchoscopy for suspected or known lung cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Bronchial liquid biopsy (ctDNA and ctRNA) collected during bronchoscopy
What this could lead to
If successful, this could lead to faster, less invasive molecular testing for lung cancer, potentially improving personalized treatment decisions.
What could go wrong
The test's sensitivity may be limited, and it might not replace traditional biopsies for all patients. The study is relatively small and early-stage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Service de Pneumologie et Oncologie Thoracique - Hôpital Tenon

    Paris, 75020, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.